Xcout Intel
Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases.
Subscribe to see Quoin Pharmaceuticals, Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Quoin Pharmaceuticals, Ltd. at a glance
Quoin Pharmaceuticals, Ltd. is a pharmaceuticals company headquartered in Ashburn, United States. It is publicly listed (QNRX) with a market capitalisation of $13.6M. Xcout tracks 24 named people at Quoin Pharmaceuticals, Ltd., including Dr. Michael Myers (Chief Executive Officer).
Quoin Pharmaceuticals, Ltd. leadership
- Dr. Michael MyersChief Executive Officer
- Sally LawlorChief Financial Officer
- Michael MyersCo-Founder, Chief Executive Officer & Chairman
- Denise CarterCo-Founder, Chief Operating Officer & Director
- Denise Bridget CarterExecutive Officer
- Denise CarterExecutive Officer
18 more named people on record for Quoin Pharmaceuticals, Ltd., with roles, board committees and tenure — see the full roster →
Investors
Quoin Pharmaceuticals, Ltd. competitors
A few of Quoin Pharmaceuticals, Ltd.'s closest competitors — see the full list of competitors and alternatives →
Auven Therapeutics is a privately held specialty pharmaceutical company focused on acquiring, developing, and commercializing late-stage and specialty medicines. It serves patients and healthcare providers through pharmaceutical products developed with industry and clinical partners.
Deciphera Pharmaceuticals, LLC is a commercial-stage biopharmaceutical company dedicated to delivering transformational medicines, such as QINLOCK, to patients for the treatment of cancer and rare diseases.
SFJ Pharmaceuticals is a privately held pharmaceutical development and investment company that helps advance drug candidates through clinical development and regulatory approval. It serves biotechnology and pharmaceutical partners by providing development funding, operational expertise, and global clinical-trial support.
Hyloris is a specialty biopharma company committed to addressing unmet medical needs through the development of pharmaceutical products and drug delivery solutions. It serves patients and healthcare providers by bringing innovative therapeutic options to the market.
Azurity Pharmaceuticals is a U.S.-based specialty pharmaceutical company that develops and commercializes medicines for underserved patient populations, including treatments for rare diseases and complex conditions. It focuses on patient-friendly dosage forms and serves healthcare providers, patients, and caregivers, including pediatric and other populations with unmet medication needs.
SCOHIA PHARMA, Inc. is a clinical-stage specialty bioventure headquartered in Fujisawa, Japan. Established in 2017, the company focuses its research and development on lifestyle-related diseases including cardiovascular, metabolic, and renal disorders.
Get Quoin Pharmaceuticals, Ltd.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Quoin Pharmaceuticals, Ltd. in Xcout Intel
- 24 named people with titles, LinkedIn and board committees
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access